Member Info for Fruitsnveg

TFG don't seem to know it. No action taken. Nada, Not a whimper from them. Strange for such a huge investor holding just shy of 30%, all that potential for change, yet utter silence. You should call them, make them aware their investment "is in the gutter". I'm sure they'd appreciate starting the week with a good laugh.

Some things are blessings in disguise.

What point is a fully paid trial when it takes as long as Strive to release data? Easily forgotten. I'd rather watch treacle evaporate than go through that again. If we are running studies in the US I would hope it's in collaboration with a BP (or little P), where more control is retained. But who knows...

Thanks Jint.

Could one be in the US and one here? I know there are other reasons for them starting simultaneously and finishing at different times. So just asking the question really, as a logical answer might be because there are 2 regulator processes involved so timeframes will differ. Granted that the answer could be simpler; e.g. different trial indications/targets/designs, or site availability, etc ...

JAxe,

Cupid’s arrows might be sharp,

But my love for you is off the (share price) chart.

Happy Valentine's day

x x x

Here's another view then; your guesstimate is wildly over-stated. Remember the company have said they are doing "small, focussed" stratified studies, not more 'Sprinter trials'. So perhaps you have based your figs on incorrect assumptions.

Mani has purposefully omitted the other significant changes mentioned on page 9 pf the Financial Report to make the financials look weaker. In the Statement of Financial Position, we now have current tax receivable of £2.4 million, and trade and other payables decreased to £3.3 million (as trade payables reduced from £4.2 million to £0.5 million in line with the reduction in the level of operating expenditure).

Mani has not included these changes in her wild guesstimate. Only an idiot, etc....

Share alledgedly worth "5p" is the subject of totally random (yet recurrent) postings by alleged "party planner" jAxe, who for some reason can't stop coming back to post about a stock he thinks is totally worthless.

lol

"I have laid out in an earlier post the numbers here just do not add up, and it is difficult to see where"

Perhaps if you were an accountant the numbers would add up. That, and using verified numbers instead of made up ones, would help.

Bore off Prof.

Spaceman quotes a decade old report based on US costings. Read the fine print. Wildly inaccurate by any measure, given the efficiencies gained in the past number of years, and no doubt another desperate attempt to erode shareholder confidence.

I think Spaceman needs to have a word with our new CFO Mr. Colliver . He who said “This is a pivotal time for the Company, as it works towards the next phase of clinical trials with SNG001. I look forward to working closely with Richard and the team in the coming months and years.” Years. As in multiple. As in, no funding issues to fret about, kind of thing....

I could be wrong, but I imagine Mr.Colliver really does know more than Spaceman, both about the company's finances, and their plans, when he made that deliberate and inightful statement.

...but he's a Financial professional, @TommyD_19, don't you know.

Lol

Yup, another Broken Record.

In other news though, the new CMO and CFO, fully onboarded in November, are busy launching us into the next phase.

And the Olivetti.

I still have great difficulty imagining the mutterings of the company bankers and advisors present when Ghia's "offer to fund a P3" (lol) was was, ahem, politely declined... Indeed. To have been a fly on the wall. The entertainment value of that alleged scenario is up there with the best of them, vying for a place in the Hall of Fictional Fame...

Another obvious reason for Radio Silence; diligence process in progress. Rigidly worded email responses. Same message. No word from FC. No word from new CMO. No conferences. No interviews. No random posting activity on LI, X, etc. It fits with the less frequent comms. It will also be out of the company's control if that is happening - the other party (or parties) would probably have stipulated only the most stringent and bare-minimum comms to be made whilst dd in process if it is.

The other possible reason is that the CMO is deep in action with the Regulator(s). This has already been communicated to investors as part of the next steps.

A final observation prompted by Doc.Dan's comment below (" they didn't even tell us where they were trialing."). Indeed. Thought provoking. So why expect a change in tack now...?

Last thing, i'd tick 1-4 on your list below DocDan. The CMO should be working on #5 already.

LOL

LOL